CLXT Calyxt

Calyxt’s High Fiber Wheat Deemed Non-Regulated by USDA

Calyxt, Inc. (NASDAQ:CLXT), a consumer-centric, food- and agriculture-focused company, today announced that the Company’s high fiber wheat product has been declared a non-regulated article under the “Am I Regulated?” process by Biotechnology Regulatory Services of the Animal and Plant Health Inspection Service (APHIS), an agency of the United States Department of Agriculture (USDA). This is Calyxt’s first consumer-centric wheat product and second wheat product (following Calyxt’s powdery mildew resistant wheat, which received non-regulated status by the USDA in February 2016), and seventh product overall, to be given this designation.

“Receiving this additional USDA letter for Calyxt’s high fiber wheat is an important next step in bringing to market food crops and plant based ingredients with the healthier characteristics for consumers and food companies,” said Federico Tripodi, Calyxt CEO. “As fiber is essential for healthy digestion, there has been a strong demand in the market for great tasting high fiber products due to their potential to not only decrease the risk of food-related chronic diseases like coronary heart disease and diabetes but also lower cholesterol as well as control weight gain. Most adults only consume about half of the recommended amount of fiber in their diet, and a single serving of Calyxt’s high fiber flour may provide the recommended daily requirement.”

Calyxt’s high fiber wheat was developed using the Company’s proprietary gene-editing technology, TALEN®, and does not contain any foreign DNA. With this USDA confirmation, Calyxt will now continue its trait validation in small- and large-scale field trials and food application development. According to industry sources, the wheat market in North America was estimated at 98 million tons in 2017, with approximately 43 percent used for human consumption in the U.S. While traditional white flour is losing ground, premium products including demand for fiber is estimated to grow at a compound annual growth rate of 11.6% globally.

“Once commercialized, Calyxt’s high fiber wheat flour can be used by food manufacturers to produce premium bakery and pasta products that consumers regularly enjoy, like bread and macaroni, all the while allowing them to potentially reach their daily fiber requirement without changing existing food preferences,” added Manoj Sahoo, Calyxt CCO. “On top of that, Calyxt’s high fiber wheat flour will have up to three times more dietary fiber than standard white flour, with enormous potential to disrupt the multi-billion-dollar industry at large.”

Calyxt’s high fiber wheat is currently in Phase 1 of the development process and on track for commercialization as early as 2020/2021. This product is now part of a total of seven Calyxt products that have been deemed non-regulated by the USDA, including powdery mildew resistant wheat, high oleic soybean, high oleic / low linolenic soybean, improved quality alfalfa, cold storable potato and reduced browning potato.

About Calyxt

Calyxt, Inc. is a consumer-centric, food- and agriculture-focused company. Calyxt is pioneering a paradigm shift to deliver healthier food ingredients, such as healthier oils and high fiber wheat, for consumers and crop traits that benefit the environment and reduce pesticide applications, such as disease tolerance, for farmers. Calyxt develops non-transgenic crops leveraging processes that occur in nature by combining its leading gene-editing technology and technical expertise with its innovative commercial strategy. Calyxt is located in Minneapolis-St. Paul, MN, and is listed on the Nasdaq market (ticker: CLXT).

For further information please visit our website: www.calyxt.com

Calyxt™ and the corporate logo are trademarks owned by Calyxt, Inc.

TALEN® is a registered trademark owned by the Cellectis Group.

Calyxt Forward-Looking Statements

This communication contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue,” the negative of these terms and other comparable terminology. These forward-looking statements, which are subject to risks, uncertainties and assumptions about us, may include projections of our future financial performance, our anticipated growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements, including those factors discussed under the caption entitled “Risk Factors” in our Annual Report on Form 10-K, along with our other filings with the U.S. Securities and Exchange Commission. We do not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

EN
21/03/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Calyxt

Calyxt Inc: 1 director

A director at Calyxt Inc bought 20,000 shares at 3.206USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

Calyxt to Host Fourth Quarter and Full Year 2020 Financial Results Con...

ROSEVILLE, Minn.--(BUSINESS WIRE)-- (NASDAQ: CLXT), a plant-based technology company, will hold a conference call on Thursday, March 4, 2021 at 4:30 p.m. Eastern time to discuss its results for the fourth quarter and full year ended December 31, 2020. A press release detailing these results will be issued prior to the call. Calyxt Chief Executive Officer Jim Blome and Chief Financial Officer Bill Koschak will host the conference call, followed by a question-and-answer session. The conference call will be accompanied by a presentation, which can be viewed during the webcast or accessed via th...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

Calyxt to Host Third Quarter 2019 Results Conference Call on Wednesday...

ROSEVILLE, Minn.--(BUSINESS WIRE)-- (NASDAQ: CLXT), a plant-based breeding and technology platform company, will hold a conference call on Wednesday, November 6, 2019 at 4:30 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2019. A press release detailing these results will be issued prior to the call. Calyxt Chief Executive Officer Jim Blome, Chief Financial Officer Bill Koschak, Chief Business Development and Supply Chain Officer Manoj Sahoo and Senior Vice President of Sales & Marketing Keith Blanks will host the conference call, followed by a question a...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch